Form 8-K Sucampo Pharmaceuticals, For: Aug 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Sucampo Pharma (SCMP) Tops Q2 EPS by 1c
August 3, 2016 8:09 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $52 million versus the consensus estimate of $48.61 million.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
... More


